Trials / Completed
CompletedNCT04976088
Clinical Trial With Diclofenac Sodium Medicated Plaster in Patients With Impact Injuries of the Limbs
Randomized, Double Blind, Parallel-groups, Non-inferiority Versus Flector® and Superiority Versus Placebo, Phase III Clinical Trial With Diclofenac Sodium 140 mg Medicated Plaster in Patients With Impact Injuries of the Limbs
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 214 (actual)
- Sponsor
- Fidia Farmaceutici s.p.a. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Phase III, multinational, multicentre, randomized, prospective, double blind, parallel groups, placebo-controlled study to evaluate the analgesic effects of Test Diclofenac Sodium 140mg medicated plaster, Reference DIEP 180 mg medicated plaster, Flector® and Placebo plaster in patients with painful and phlogistic disease due to acute traumatic events of the limbs.
Detailed description
This will be a Phase III, multinational, multicentre, randomized, prospective, double blind, parallel groups, placebo-controlled study to evaluate the analgesic effects of Test Diclofenac Sodium 140mg medicated plaster (once a day), Reference DIEP 180 mg medicated plaster, Flector® (once a day) and Placebo plaster once a day (i.e. the placebo arm) in patients with painful and phlogistic (inflammatory response) disease due to acute traumatic events (injury/contusion) of the limbs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diclofenac Sodium 140 mg medicated plaster | Test product: Diclofenac Sodium 140 mg medicated plaster, topical application once a day |
| DRUG | Diclofenac epolamine (DIEP) 180mg medicated plaster, Flector | Reference product: Active-comparator, Diclofenac epolamine (DIEP) 180 mg medicated plaster, Flector®, topical application once a day |
| DRUG | Placebo | Placebo: Placebo plaster, topical application once a day. |
Timeline
- Start date
- 2018-05-25
- Primary completion
- 2018-10-27
- Completion
- 2018-10-27
- First posted
- 2021-07-26
- Last updated
- 2023-10-02
Locations
16 sites across 3 countries: Germany, Hungary, Italy
Source: ClinicalTrials.gov record NCT04976088. Inclusion in this directory is not an endorsement.